Skip to content
High Tech Series B Founded 2014

Hy2Care

Developer of a hydrogel implant for cartilage defect repair. It facilitates the natural repair of cartilage defects in joints. The hydrogel is biocompatible, mimicking natural joint tissue polymers to protect the injured area and encourage healing. It provides a scaffold for the patient cells to regenerate cartilage to alleviate pain and restore joint function. It addresses the significant unmet need for effective…

📍 Enschede, Netherlands · Advanced Materials,

Funding snapshot

Last roundSeries B
Amount$5M
Date14 May 2025
Total raised$15M
Team size16

About

Developer of a hydrogel implant for cartilage defect repair. It facilitates the natural repair of cartilage defects in joints. The hydrogel is biocompatible, mimicking natural joint tissue polymers to protect the injured area and encourage healing. It provides a scaffold for the patient cells to regenerate cartilage to alleviate pain and restore joint function. It addresses the significant unmet need for effective cartilage repair, preventing the progression to osteoarthritis. The company was founded in 2014 and headquartered in Enschede, Netherlands. It has raised $15.5M in series b funding, with backing from Brightlands Venture Partners, ReumaNederland, Startupbootcamp, Europa, and others. The company operates in the High Tech - Advanced Materials, Chemicals and Materials Tech - Advanced Materials, Life Sciences - Orthopedics space.

Business model

Advanced Materials > Biomaterials > Biomimetics > Hydrogel,

Orthopedics > Medical Devices > Therapies > Regenerative medicine > Hydrogel Based

Institutional investors

Brightlands Venture Partners ReumaNederland Startupbootcamp Europa LIOF European Innovation Council

Latest coverage

No articles yet.

Raising like Hy2Care?

Analyze your pitch deck before your next raise.

Analyze My Deck →